Evidence map›Paper›PMID 38383131›Full record

ArticleBMJ case reports2024

A treatable inborn error of metabolism presenting in the sixth decade.

Sarah-Jane Martin, Amy Davidson, Sheena Murdoch, Johann Selvarajah

Open access · greenAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Sarah-Jane MartinNHS Greater Glasgow and Clyde, Institute of Neurological Sciences, Glasgow, UK.ORCID http://orcid.org/0000-0002-3600-4527
Amy DavidsonNHS Greater Glasgow and Clyde, Institute of Neurological Sciences, Glasgow, UK.
Sheena MurdochDepartment of Neurology, Raigmore Hospital, Inverness, UK.
Johann SelvarajahNHS Greater Glasgow and Clyde, Institute of Neurological Sciences, Glasgow, UK johann.selvarajah@glasgow.ac.uk.
NHS Greater Glasgow and Clyde · GBRaigmore Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phenylketonuria (PKU) is an inborn error of amino acid metabolism. If untreated, PKU can result in global developmental delay, learning difficulties or seizures. For that reason, PKU is included in the UK neonatal screening programme. We describe a patient in his sixth decade presenting with progressive cognitive decline and spasticity, in whom a diagnosis of PKU was eventually reached. We note that although we currently have a robust neonatal screening programme, this has not always been the case. Patients born before 1969 were not screened, and tests used in early screening programmes were less sensitive than those used today. This case serves as a reminder that inherited metabolic disorders may present in later life and may mimic the neurocognitive and radiological picture of other white matter syndromes.

Indexed as

PhenylketonuriasHumansInfant, NewbornNeonatal ScreeningNeuro geneticsNeuroimaging

Identifiers

PMID38383131
PMCPMC10882449
OpenAlexW4392005961

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.